《大行報告》花旗:百勝中國(09987.HK)次季核心純利符預期 維持「買入」評級
花旗發表研究報告指,百勝中國(09987.HK)第二季核心純利按年增長1.4倍,符合預期。新店的銷售貢獻在次季繼續推動營收擴張和營業收入增長。該行維持2023年全年核心純利預測不變,即8.2億美元,又維持該股「買入」評級,目標價573.56元。
該行提到,集團管理層重申下半年將繼續開展營銷活動,以抓住第三季夏天旺季的銷售機會。雖然第三季的營業利潤率和餐廳利潤率均較高,但管理層預計,效率提高和成本結構的調整長遠將繼續有利於集團的盈利能力。集團維持其淨開1,100間至1,300間銷售點及全年資本開支7億至9億美元的目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.